Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

It’s measured using two numbers: Systolic pressure is the pressure ... Use a blood pressure chart to interpret your blood pressure readings. At-home blood pressure monitoring and lifestyle ...

Researchers have developed a new polygenic risk score saliva test that outperforms PSA in detecting prostate cancer among men with high genetic risk. According to new study published in the New ...

At-home genetic test could transform screening, catching more life-threatening cases A new study has revealed that a saliva test at home can more accurately detect aggressive prostate cancer than ...